BCG vaccine nesting birds and rusted electrical conduits. The resulting closure of the plant for over two years resulting in shortages of bladder cancer and tuberculosis vaccines. On October 29, 2014 Health Canada gave the permission for Sanofi to resume production of BCG. The global supply situation was analyzed in 2017 and concluded that the global supply is sufficient to meet forecasted BCG vaccine demand but risks for shortages remain mainly due to supply concentration. A weakened strain of bovine tuberculosis bacillus, "Mycobacterium bovis" is specially subcultured in a culture medium, usually Middlebrook 7H9. Some BCG vaccines are freeze dried and become
Inoculation needle needle-oriented culture methods. The application of inoculation needles focuses on the inoculation and isolation of very defined regions of the cultures and the requirements of least disturbance between two closely crowded microbial colonies. It can also be used in harpooning under a low magnification microscope. Streaking on streak plates, fish tail inoculation of slant cultures and the inoculation of stab cultures can be done with the inoculation needle. Stab cultures specifically require the inoculation needle and is used to study cell motility, microbial oxygen requirements using Thioglycolate cultures, and the gelatin liquefaction of bacteria. The inoculation needle is sterilized using